Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 15, Issue 8, Pages 13299-13316
Publisher
MDPI AG
Online
2014-07-30
DOI
10.3390/ijms150813299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer
- (2014) Xavier Filella et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI
- (2013) Gisele Leyten et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
- (2013) Vincenzo Scattoni et al. JOURNAL OF UROLOGY
- Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml
- (2013) Matteo Ferro et al. PLoS One
- Prostate cancer screening and the management of clinically localized disease
- (2013) T. J. Wilt et al. BMJ-British Medical Journal
- Correlation of UrineTMPRSS2:ERGandPCA3to ERG+ and Total Prostate Cancer Burden
- (2012) Allison Young et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy
- (2012) Xavier Durand et al. BJU INTERNATIONAL
- The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
- (2012) A. Pettersson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
- (2012) Matteo Ferro et al. CLINICA CHIMICA ACTA
- Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [-2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- Relationship between prostate cancer gene 3 (PCA3) and characteristics of tumor aggressiveness
- (2012) Herbert Augustin et al. PROSTATE
- Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy
- (2012) Sisto Perdonà et al. PROSTATE
- The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance
- (2011) Hein van Poppel et al. BJU INTERNATIONAL
- Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy
- (2011) Vladimir Mouraviev et al. BJU INTERNATIONAL
- One statistical test is sufficient for assessing new predictive markers
- (2011) Andrew J Vickers et al. BMC Medical Research Methodology
- Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting
- (2011) Giorgio Guazzoni et al. EUROPEAN UROLOGY
- Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
- (2011) Marco Auprich et al. EUROPEAN UROLOGY
- Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer
- (2011) Giorgio Guazzoni et al. EUROPEAN UROLOGY
- Urinary PCA3 Score Predicts Prostate Cancer Multifocality
- (2011) Virginie Vlaeminck-Guillem et al. JOURNAL OF UROLOGY
- Prognostic Significance of Tumor Volume in Radical Prostatectomy and Needle Biopsy Specimens
- (2011) Jonathan I. Epstein JOURNAL OF UROLOGY
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- Pre-analytical in-vitro stability of [-2]proPSA in blood and serum
- (2010) Axel Semjonow et al. CLINICAL BIOCHEMISTRY
- Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
- (2010) Flip H. Jansen et al. EUROPEAN UROLOGY
- Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
- (2010) Marco Auprich et al. EUROPEAN UROLOGY
- Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
- (2010) Guillaume Ploussard et al. EUROPEAN UROLOGY
- [-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
- (2010) Brian V. Le et al. JOURNAL OF UROLOGY
- Traditional Statistical Methods for Evaluating Prediction Models Are Uninformative as to Clinical Value: Towards a Decision Analytic Framework
- (2010) Andrew J. Vickers et al. SEMINARS IN ONCOLOGY
- PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols
- (2010) Michael A. Liss et al. WORLD JOURNAL OF UROLOGY
- TMPRSS2:ERGfusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis
- (2009) KARI ROSTAD et al. APMIS
- ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
- (2009) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer
- (2009) Daphne Hessels et al. PROSTATE
- Urinary Prostate Cancer 3 Test: Toward the Age of Reason?
- (2009) Virginie Vlaeminck-Guillem et al. UROLOGY
- PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance
- (2008) Hiroyuki Nakanishi et al. JOURNAL OF UROLOGY
- PCA3 Score Before Radical Prostatectomy Predicts Extracapsular Extension and Tumor Volume
- (2008) Eric J. Whitman et al. JOURNAL OF UROLOGY
- Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results
- (2008) Martijn P.M.Q. van Gils et al. PROSTATE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now